These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25787736)

  • 1. Clinical translation of controlled protein delivery systems for tissue engineering.
    Spiller KL; Vunjak-Novakovic G
    Drug Deliv Transl Res; 2015 Apr; 5(2):101-15. PubMed ID: 25787736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled drug release for tissue engineering.
    Rambhia KJ; Ma PX
    J Control Release; 2015 Dec; 219():119-128. PubMed ID: 26325405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery in soft tissue engineering.
    Ladewig K
    Expert Opin Drug Deliv; 2011 Sep; 8(9):1175-88. PubMed ID: 21679089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release of drugs in electrosprayed nanoparticles for bone tissue engineering.
    Jayaraman P; Gandhimathi C; Venugopal JR; Becker DL; Ramakrishna S; Srinivasan DK
    Adv Drug Deliv Rev; 2015 Nov; 94():77-95. PubMed ID: 26415888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogels for protein delivery in tissue engineering.
    Censi R; Di Martino P; Vermonden T; Hennink WE
    J Control Release; 2012 Jul; 161(2):680-92. PubMed ID: 22421425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrices and scaffolds for protein delivery in tissue engineering.
    Tessmar JK; Göpferich AM
    Adv Drug Deliv Rev; 2007 May; 59(4-5):274-91. PubMed ID: 17544542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate-programming of nano-particulate delivery systems for smart bioactive scaffolds in tissue engineering.
    Izadifar M; Haddadi A; Chen X; Kelly ME
    Nanotechnology; 2015 Jan; 26(1):012001. PubMed ID: 25474543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of endogenous regenerative technology for in situ regenerative medicine.
    Anitua E; Sánchez M; Orive G
    Adv Drug Deliv Rev; 2010 Jun; 62(7-8):741-52. PubMed ID: 20102730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioengineering approaches to controlled protein delivery.
    Kobsa S; Saltzman WM
    Pediatr Res; 2008 May; 63(5):513-9. PubMed ID: 18427296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release scaffolds for bone tissue engineering.
    Cartmell S
    J Pharm Sci; 2009 Feb; 98(2):430-41. PubMed ID: 18481312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart regeneration after myocardial infarction using synthetic biomaterials.
    Pascual-Gil S; Garbayo E; Díaz-Herráez P; Prosper F; Blanco-Prieto MJ
    J Control Release; 2015 Apr; 203():23-38. PubMed ID: 25665866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrospun cellular microenvironments: Understanding controlled release and scaffold structure.
    Szentivanyi A; Chakradeo T; Zernetsch H; Glasmacher B
    Adv Drug Deliv Rev; 2011 Apr; 63(4-5):209-20. PubMed ID: 21145932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of controlled delivery systems for regenerative therapeutics.
    Khang G; Tripathy N
    Ther Deliv; 2014 Oct; 5(10):1053-5. PubMed ID: 25418264
    [No Abstract]   [Full Text] [Related]  

  • 14. Biodegradable elastomers in drug delivery.
    Amsden BG
    Expert Opin Drug Deliv; 2008 Feb; 5(2):175-87. PubMed ID: 18248317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porous PLGA scaffolds for controlled release of naked and polyethyleneimine-complexed DNA.
    Ravi N; Gupta G; Milbrandt TA; Puleo DA
    Biomed Mater; 2012 Oct; 7(5):055007. PubMed ID: 22909549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How can microsphere-mediated delivery of small molecules serve as a novel tool for engineering tissues from stem cells?
    Willerth SM
    Ther Deliv; 2019 Nov; 10(11):671-674. PubMed ID: 31608826
    [No Abstract]   [Full Text] [Related]  

  • 17. Review paper: critical issues in tissue engineering: biomaterials, cell sources, angiogenesis, and drug delivery systems.
    Naderi H; Matin MM; Bahrami AR
    J Biomater Appl; 2011 Nov; 26(4):383-417. PubMed ID: 21926148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional glass-derived scaffolds for bone tissue engineering: current trends and forecasts for the future.
    Baino F; Vitale-Brovarone C
    J Biomed Mater Res A; 2011 Jun; 97(4):514-35. PubMed ID: 21465645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue engineered drug delivery vehicles: Methods to monitor and regulate the release behavior.
    Gil CJ; Li L; Hwang B; Cadena M; Theus AS; Finamore TA; Bauser-Heaton H; Mahmoudi M; Roeder RK; Serpooshan V
    J Control Release; 2022 Sep; 349():143-155. PubMed ID: 35508223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research and application of drug controlled release technique in tissue engineering].
    Wang SG; Cai Q; Lü Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Sep; 15(5):280-5. PubMed ID: 11761854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.